Evaluation of two different albumin depletion strategies for improved analysis of human CSF by SELDI-TOF-MS

Clinical Biochemistry

Volumn 42, Issue 10-11, 2009, Pages 1136-1143

  Siegmund, Robert ^a   Kiehntopf, Michael ^a   Deufel, Thomas ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Albumin; Albumin depletion; CSF, filter; SELDI

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER;

ANALYTICAL EQUIPMENT; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN DEPLETION; PROTEIN DETERMINATION; RELIABILITY; REPRODUCIBILITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ALBUMINS; FILTRATION; HUMANS; MOLECULAR WEIGHT; REAGENT KITS, DIAGNOSTIC; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 67349147502     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.02.028     Document Type: Article

References (33)

1. Aldred S., Grant M.M., and Griffiths H.R. The use of proteomics for the assessment of clinical samples in research. Clin. Biochem. 37 (2004) 943-952
2. Rodland K.D. Proteomics and cancer diagnosis: the potential of mass spectrometry. Clin. Biochem. 37 (2004) 579-583
3. Poon T.C. Opportunities and limitations of SELDI-TOF-MS in biomedical research: practical advices. Expert. Rev. Proteomics. 4 (2007) 51-65
4. Kiehntopf M., Siegmund R., and Deufel T. Use of SELDI-TOF mass spectrometry for identification of new biomarkers: potential and limitations. Clin. Chem. Lab. Med. 45 (2007) 1435-1449
5. Weston A.D., and Hood L. Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. J. Proteome. Res. 3 (2004) 179-196
6. Anderson N.L., and Anderson N.G. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 1 (2002) 845-867
7. Echan L.A., Tang H.Y., Ali-Khan N., Lee K., and Speicher D.W. Depletion of multiple high-abundance proteins improves protein profiling capacities of human serum and plasma. Proteomics 5 (2005) 3292-3303
8. Zolotarjova N., Martosella J., Nicol G., Bailey J., Boyes B.E., and Barrett W.C. Differences among techniques for high-abundant protein depletion. Proteomics 5 (2005) 3304-3313
9. Li X., Gong Y., Wang Y., et al. Comparison of alternative analytical techniques for the characterisation of the human serum proteome in HUPO Plasma Proteome Project. Proteomics 5 (2005) 3423-3441
10. Kim M.R., and Kim C.W. Human blood plasma preparation for two-dimensional gel electrophoresis. J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci. 849 (2007) 203-210
11. Chromy B.A., Gonzales A.D., Perkins J., et al. Proteomic analysis of human serum by two-dimensional differential gel electrophoresis after depletion of high-abundant proteins. J. Proteome. Res. 3 (2004) 1120-1127
12. Zheng W Chodobski A. The Blood-Cerebrospinal Barrier (2004), CRC Press, New York
13. Rapoport S.I., and Pettigrew K.D. A heterogenous, pore-vesicle membrane model for protein transfer from blood to cerebrospinal fluid at the choroid plexus. Microvasc. Res. 18 (1979) 105-119
14. Reiber H., and Felgenhauer K. Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin. Chim. Acta. 163 (1987) 319-328
15. Davidsson P., and Sjogren M. The use of proteomics in biomarker discovery in neurodegenerative diseases. Dis. Markers 21 (2005) 81-92
16. Rohlff C. Proteomics in neuropsychiatric disorders. Int. J. Neuropsychopharmacol. 4 (2001) 93-102
17. Romeo M.J., Espina V., Lowenthal M., Espina B.H., Petricoin III E.F., and Liotta L.A. CSF proteome: a protein repository for potential biomarker identification. Expert. Rev. Proteomics. 2 (2005) 57-70
18. Carrette O., Demalte I., Scherl A., et al. A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease. Proteomics 3 (2003) 1486-1494
19. Khwaja F.W., Duke-Cohan J.S., Brat D.J., and Van Meir E.G. Attractin is elevated in the cerebrospinal fluid of patients with malignant astrocytoma and mediates glioma cell migration. Clin. Cancer. Res. 12 (2006) 6331-6336
20. Ruetschi U., Zetterberg H., Podust V.N., et al. Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF. Exp. Neurol. 196 (2005) 273-281
21. Norwitz E.R., Tsen L.C., Park J., et al. Discriminatory proteomic biomarker analysis identifies free hemoglobin in the cerebrospinal fluid of women with severe preeclampsia. Am. J. Obstet. Gynecol. 193 (2005) 957-964
22. Khwaja F.W., Nolen J.D., Mendrinos S., et al. Proteomic analysis of cerebrospinal fluid discriminates malignant and nonmalignant disease of the central nervous system and identifies specific protein markers. Proteomics 6 (2006) 6277-6287
23. Guerreiro N., Gomez-Mancilla B., and Charmont S. Optimization and evaluation of surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry for protein profiling of cerebrospinal fluid. Proteome Sci. 4 (2006) 7
24. Li J., Orlandi R., White C.N., et al. Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry. Clin. Chem. 51 (2005) 2229-2235
25. Paradis V., Degos F., Dargere D., et al. Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases. Hepatology 41 (2005) 40-47
26. Liu X., Li L., Zhang G., Sheng G., and Xu W. An approach to the characterization of serum low-molecular weight proteins/peptides in liver injury using SELDI-TOF MS and factor analysis. Clin. Biochem. 40 (2007) 1266-1271
27. Ogawa K., Kojima T., Matsumoto C., et al. Identification of a predictive biomarker for the beneficial effect of a Kampo (Japanese traditional) medicine keishibukuryogan in rheumatoid arthritis patients. Clin. Biochem. 40 (2007) 1113-1121
28. Bjorhall K., Miliotis T., and Davidsson P. Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics 5 (2005) 307-317
29. Ahmed N., Barker G., Oliva K., et al. An approach to remove albumin for the proteomic analysis of low abundance biomarkers in human serum. Proteomics 3 (2003) 1980-1987
30. Linke T., Doraiswamy S., and Harrison E.H. Rat plasma proteomics: effects of abundant protein depletion on proteomic analysis. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 849 (2007) 273-281
31. Seam N., Gonzales D.A., Kern S.J., Hortin G.L., Hoehn G.T., and Suffredini A.F. Quality control of serum albumin depletion for proteomic analysis. Clin. Chem. 53 (2007) 1915-1920
32. Granger J., Siddiqui J., Copeland S., and Remick D. Albumin depletion of human plasma also removes low abundance proteins including the cytokines. Proteomics 5 (2005) 4713-4718
33. Zhou M., Lucas D.A., Chan K.C., et al. An investigation into the human serum "interactome". Electrophoresis 25 (2004) 1289-1298